# Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-with-maintenance-olaparib-at-a-7-year-follow-up-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul DiSilvestro,Susana Banerjee,Nicoletta Colombo,Giovanni Scambia,Byoung‐Gie Kim,Ana Oaknin,Michael Friedländer,Alla Lisyanskaya,Anne Floquet,Alexandra Léary,Gabe S. Sonke,Charlie Gourley,Amit M. Oza,Antonio González-Martı́n,Carol Aghajanian,William H. Bradley,Cara Mathews,Joyce F. Liu,John McNamara,Elizabeth Lowe,Mei-Lin Ah-See,Kathleen N. Moore,on behalf of the SOLO1 Investigators |
| Citations | 488 |
| DOI | 10.1200/jco.22.01549 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.22.01549 |
| OpenAlex ID | https://openalex.org/W4295078726 |
| PMID | 36082969 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Paul DiSilvestro](https://scholariq.org/researchers/paul-disilvestro/)
- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)
- [Giovanni Scambia](https://scholariq.org/researchers/giovanni-scambia/)
- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)
- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)
- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)

## Paper funders

- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [National Cancer Institute](https://scholariq.org/funders/national-cancer-institute/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.